A Real-World Evaluation of Atezolizumab Plus Platinum-Etoposide Chemotherapy in Patients With Extensive-Stage SCLC in Canada

INTRODUCTION: The real-world data evaluating treatment outcomes of atezolizumab plus carboplatin-etoposide chemotherapy (atezolizumab) for extensive-stage SCLC (ESCLC) are lacking. Our objective was to evaluate real-world outcomes of ESCLC treated with atezolizumab. METHODS: A retrospective analysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Elegbede, Anifat A., Gibson, Amanda J., Fung, Andrea S., Cheung, Winson Y., Dean, Michelle L., Bebb, D. Gwyn, Pabani, Aliyah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628038/
https://www.ncbi.nlm.nih.gov/pubmed/34877555
http://dx.doi.org/10.1016/j.jtocrr.2021.100249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628038/
https://www.ncbi.nlm.nih.gov/pubmed/34877555
http://dx.doi.org/10.1016/j.jtocrr.2021.100249

Ejemplares similares